Polaryx Therapeutics, Inc. (PLYX)
About Polaryx Therapeutics, Inc.
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$9.0M
- Total assets
- $5.2M
- Market cap
- $116.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $116.1M
- Shares outstanding
- 56.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 2, 2026
Polaryx Therapeutics, Inc. (PLYX) Stock Price
- Reported a net loss of $9.0M.
- Trading 94% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Polaryx Therapeutics, Inc..
Write a review
Polaryx Therapeutics, Inc.: frequently asked questions
Is Polaryx Therapeutics, Inc. an American company?
Polaryx Therapeutics, Inc. is a US-based company headquartered in Paramus, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Polaryx Therapeutics, Inc. headquartered?
Polaryx Therapeutics, Inc. is headquartered in Paramus, New Jersey, United States.
Is Polaryx Therapeutics, Inc. publicly traded?
Yes — Polaryx Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol PLYX on the NASDAQ.
What does Polaryx Therapeutics, Inc. do?
Polaryx Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
